Convalescent Plasma Therapy for Hospitalized Patients With COVID-19

Clinical trial NCT05077930 · COMPLETED

Trial details

NCT number: NCT05077930
Sponsor: Tânia Portella Costa
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Convalescent Plasma SARS-CoV-2 Pneumonia Coronavirus Infections Respiratory Tract Diseases

Start date: 2022-01-06
Primary completion: 2022-04-04
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.